Insmed (INSM) EBITDA (2011 - 2026)
Insmed (INSM) reported EBITDA of $3.71 million for Q2 2026, compared with -$309.13 million a year earlier.
Powered by 
Analysis
Insmed (INSM) EBITDA (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Insmed's EBITDA came in at -$820.79 million; for FY2025, it came in at -$1.23 billion.
- By year, EBITDA came in at -$867.2 million in FY2024, -$699.05 million in FY2023, -$446.97 million in FY2022 and -$360.91 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly EBITDA in data going back to Q1 2011.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$148.31 million (Q1 2026), -$314.19 million (Q4 2025) and -$362.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Insmed | 25.69 Bn | 20.19 Bn | 358.27 Mn | 3.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.71 Mn |
| Mar 31, 2026 | -148.31 Mn |
| Dec 31, 2025 | -314.19 Mn |
| Sep 30, 2025 | -362.01 Mn |
| Jun 30, 2025 | -309.13 Mn |
| Mar 31, 2025 | -244.99 Mn |
| Dec 31, 2024 | -227.63 Mn |
| Sep 30, 2024 | -210.71 Mn |
| Jun 30, 2024 | -286.21 Mn |
| Mar 31, 2024 | -142.65 Mn |
| Dec 31, 2023 | -175.53 Mn |
| Sep 30, 2023 | -144.91 Mn |
| Jun 30, 2023 | -232.95 Mn |
| Mar 31, 2023 | -145.65 Mn |
| Dec 31, 2022 | -148.01 Mn |
| Sep 30, 2022 | -125.58 Mn |
| Jun 30, 2022 | -86.10 Mn |
| Mar 31, 2022 | -87.28 Mn |
| Dec 31, 2021 | -95.70 Mn |
| Sep 30, 2021 | -100.12 Mn |
API Access
Insmed EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();